Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 6/20 | 0.62 |
| ▸ | PLK1 | P53350 | 1/20 | 0.62 |
| ▸ | THRA | P10827 | 7/20 | 0.61 |
| ▸ | THRB | P10828 | 7/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | RARA | P10276 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | MTOR | P42345 | 1/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.51 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8103655 | 0.96 | RARB (0.59) | RARBPLK1THRATHRBALDH1A1 | |
| SCHEMBL12656104 | 0.94 | RARB (0.72) | RARBPLK1THRATHRBALDH1A1 | |
| SCHEMBL158152 | 0.94 | THRA (0.67) | RARBTHRATHRBALDH1A1MEN1 | |
| SCHEMBL8728345 | 0.92 | THRA (0.70) | RARBTHRATHRBALDH1A1MEN1 | |
| SCHEMBL1021352 | 0.92 | THRA (0.70) | RARBTHRATHRBALDH1A1MEN1 | |
| SCHEMBL9431010 | 0.92 | THRA (0.70) | RARBTHRATHRBALDH1A1MEN1 | |
| SCHEMBL269399 | 0.92 | THRA (0.70) | RARBTHRATHRBALDH1A1MEN1 | |
| SCHEMBL8960387 | 0.92 | THRA (0.70) | RARBTHRATHRBALDH1A1MEN1 | |
| SCHEMBL17272985 | 0.92 | THRA (0.70) | RARBTHRATHRBALDH1A1MEN1 | |
| SCHEMBL1020543 | 0.92 | THRA (0.70) | RARBTHRATHRBALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 492 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118955940-A | Agricultural and forestry waste-based thermoplastic plastic and preparation method thereof | 西南林业大学 | 2024-11-15 | — | — | CN | claimed |
| CN-114853627-B | Substituted docosahexaenoic amide ethyl benzoate derivative and preparation method and application thereof | 自然资源部第三海洋研究所 | 2023-06-20 | — | — | CN | claimed |
| CN-114853627-A | Substituted docosahexaenoic acid diethyl ester derivative as well as preparation method and application thereof | 自然资源部第三海洋研究所 | 2022-08-05 | — | — | CN | claimed |
| CN-109574842-B | Vegetable oil polyalcohol and preparation method and application thereof | 南京工业大学 | 2020-05-05 | — | — | CN | claimed |
| CN-108299150-A | The synthetic method of 4- n-butylbenzene formyl chlorides | 江苏佳麦化工有限公司 | 2018-07-20 | — | — | CN | claimed |
| US-6214990-B1 | 2,9-BIS(4-METHOXYBENZOYLOXY),3,10-DIMETHOXY,6,13-DICHLORO -PHENODIOXAZINE, FOR EXAMPLE; DYE HAS NARROW LIGHT ABORPTION BAND AND HIGH DICHROIC RATIO | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-04-10 | — | — | US | claimed |
| EP-0440329-A1 | S-substituted carbonyl substituted betathioacrylamide biocides and fungicides | ROHM AND HAAS COMPANY (US) | 1991-08-07 | — | — | EP | claimed |
| US-20250248990-A1 | QUINOLINES THAT MODULATE SERCA AND THEIR USE FOR TREATING DISEASE | NEURODON CORPORATION | 2025-08-07 | — | — | US | disclosed |
| US-20250250249-A1 | NOVEL SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS D-AMINO ACID OXIDASE (DAAO) INHIBITORS | NATIONAL YANG MING CHIAO TUNG UNIVERSITY (TW) | 2025-08-07 | — | — | US | disclosed |
| US-12312326-B2 | Substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors | Tseng, Yufeng Jane (US) | 2025-05-27 | — | — | US | disclosed |
| WO-2024235876-A1 | PYRIDOPYRIMIDINE DERIVATIVES FOR USE AS ANTIVIRAL AGENTS | FERNANDEZ CAPETILLO OSCAR (SE) | 2024-11-21 | — | — | WO | disclosed |
| US-12144806-B2 | Quinolines that modulate SERCA and their use for treating disease | NEURODON CORPORATION (US) | 2024-11-19 | — | — | US | disclosed |
| CN-118955940-A | Agricultural and forestry waste-based thermoplastic plastic and preparation method thereof | 西南林业大学 | 2024-11-15 | — | — | CN | disclosed |
| US-4284813-A | Benzamide derivatives and herbicidal composition containing the same | HODOGAYA CHEMICAL CO., LTD. (JP) | 1981-08-18 | — | — | US | disclosed |
| US-4200580-A | Dioxanylphenyl benzoate liquid crystal compounds | TIMEX CORPORATION (US) | 1980-04-29 | — | — | US | disclosed |
| US-4167489-A | AN IMINE-ESTER AROMATIC COMPOUND | BBC BROWN BOVERI & COMPANY, LIMITED (CH) | 1979-09-11 | — | — | US | disclosed |
| US-4136053-A | BIPHENYL ESTERS AND LIQUID CRYSTALLINE MIXTURES COMPRISING THEM | MERCK PATENT GESELLSCHAFT MIT BESCHANKTER HAFTUNG (DE) | 1979-01-23 | — | — | US | disclosed |
| US-4065489-A | Biphenyl esters and liquid crystalline mixtures comprising them | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-12-27 | — | — | US | disclosed |
| US-4058478-A | P-ALKYLBENZOIC ACID P'-CYANOPHENYL ESTER | HOFFMANN-LA ROCHE INC. (US) | 1977-11-15 | — | — | US | disclosed |
| US-3963311-A | Liquid crystal esters | HOFFMANN-LA ROCHE INC. (US) | 1976-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250250249-A1 | NOVEL SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS D-AMINO ACID OXIDASE (DAAO) INHIBITORS | DAO, DDO, DDC | RARB 1403/4885PLK1 4346/4885THRA 3513/4885 |
| US-12144806-B2 | Quinolines that modulate SERCA and their use for treating disease | ATP2A1, ATP2A3, ATP2A2 | RARB 3368/4885PLK1 3535/4885THRA 2810/4885 |
| US-20250248990-A1 | QUINOLINES THAT MODULATE SERCA AND THEIR USE FOR TREATING DISEASE | ATP2A1, ATP2A3, ATP2A2 | RARB 3368/4885PLK1 3535/4885THRA 2810/4885 |
| US-12312326-B2 | Substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors | DAO, DDO, DDC | RARB 1716/4885PLK1 4254/4885THRA 3862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.